---
title: "Belite Bio (BLTE.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/BLTE.US/norm.md"
symbol: "BLTE.US"
name: "Belite Bio"
parent: "https://longbridge.com/zh-CN/quote/BLTE.US.md"
datetime: "2026-03-12T04:00:06.796Z"
locales:
  - [en](https://longbridge.com/en/quote/BLTE.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BLTE.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BLTE.US/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/BLTE.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/BLTE.US/norm.md)


# Belite Bio (BLTE.US) — 财务报表

## 利润表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.6992 | -0.6529 | -0.5008 | -0.4450 | -0.3210 |
| ROE | -19.39% | -40.93% | -42.40% | -37.58% | -31.32% |
| Revenue | - | - | - | - | - |
| Net income | -25.32M | -21.69M | -16.32M | -14.28M | -10.10M |
| Operating income | -28.08M | -23.02M | -17.60M | -15.52M | -11.46M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 780.56M | 282.39M | 156.41M | 164.20M | 152.13M |
| Leverage | 1.01 | 1.03 | 1.04 | 1.04 | 1.04 |
| BVPS | 19.59 | 7.86 | 4.60 | 4.86 | 4.58 |
| Turnover | - | - | - | - | - |
| Cash & STI | - | 275.61M | - | - | 145.15M |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | 826000.00 | - | - | 965000.00 |
| Net debt | - | -275.10M | - | - | -144.61M |

## 现金流量表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | - | - | - | - | - |
| Investing CF | - | - | - | - | - |
| Financing CF | - | - | - | - | - |
| Free CF | - | - | - | - | - |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |